NDC 52544-348 - Triamterene and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52544-348
- Package NDCs from labels
- 52544-348-30, 52544-348-01, 52544-348-05, 52544-348-10
- Manufacturer
- State of Florida DOH Central Pharmacy
- Effective date
- 2010-06-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Triamterene and Hydrochlorothiazide - State of Florida DOH Central Pharmacy | State of Florida DOH Central Pharmacy | 2010-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| Triamterene and Hydrochlorothiazide Tablets USP Rx only | Watson Laboratories, Inc. | 2008-01-24 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52544-348-01 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 52544-348-05 | Triamterene and Hydrochlorothiazide | 500 in 1 BOTTLE | TABLET | 500 | 1 | |
| 52544-348-10 | Triamterene and Hydrochlorothiazide | 1000 in 1 BOTTLE | TABLET | 1000 | 1 | |
| 52544-348-30 | Triamterene and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | b4f5dd93-5f44-4c8c-9e3b-89ab1fa5a7fd | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Direct_Rx | 05156717-fe1b-22f1-e063-6394a90a3d10 | 2025-01-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | Ajanta Pharma USA Inc. | 8b78d7ad-22a8-4a9f-afb5-d18f0a4e6d36 | 2025-01-22 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d8284747-07b6-9775-e053-2a95a90ad52d | 2025-01-21 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct Rx | d88ad738-a915-7679-e053-2a95a90a58c7 | 2025-01-21 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 93f6a018-8b3d-4f40-be25-902daec19aea | 2025-01-21 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | DIRECT RX | cbe5e01e-67ca-f8a2-e053-2995a90a0d15 | 2025-01-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | cf4278a3-fbb7-a8ab-e053-2a95a90abc0f | 2025-01-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | d1ed9593-a587-55bb-e053-2995a90a8a9a | 2025-01-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | d1ee193e-bf78-3134-e053-2a95a90a65d2 | 2025-01-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | DirectRx | d2021060-94d7-3e1d-e053-2995a90a10ee | 2025-01-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Direct_Rx | 8de04bf2-83dd-c494-e053-2a95a90abade | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| amlodipine,valsartan and hydrochlorothiazide | AMLODIPINE,VALSARTAN AND HYDROCHLOROTHIAZIDE | Macleods Pharmaceuticals Limited | 1ea4f227-b97a-49f1-bbc3-1dede2c1866d | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | American Health Packaging | ba764ce4-36fe-4aa4-96a4-d0479b875b4f | 2025-01-08 | Warnings, Adverse reactions | 310812 WS821Z52LQ 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Advanced Rx Pharmacy of Tennessee, LLC | ecac0280-6faa-e7f3-e053-2995a90a2bd9 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Micardis HCT | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | b078dae2-664d-4144-847a-3b9d9b557402 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 4a2c2b8f-1479-4555-9ba8-ca4407003296 | 2024-12-27 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Quality Care Products, LLC | a6241e63-1952-4dfa-ba94-c406059501dd | 2024-12-19 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Quality Care Products LLC | a2de8e26-ef5a-41c7-888b-990629b11145 | 2024-12-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Lake Erie Medical DBA Quality Care Products LLC | 9e6a0c83-1494-44ca-90e0-3f43fa8ec746 | 2024-12-16 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.